Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DENTAL PRODUCTS ADVISORY PANEL CHAIR RESIGNS FOLLOWING RELEASE OF IG PROBE; NOV. 3-4 PANEL MEETING WILL REVISIT UNCLASSIFIED MUSCLE MONITORING DEVICES

This article was originally published in The Gray Sheet

Executive Summary

Charles Bertolami, DDS, University of San Francisco voluntarily resigned as chairman of FDA's Dental Products Advisory Panel following an investigation by the HHS Office of the Inspector General, according to a letter from FDA Deputy Commissioner for External Affairs Sharon Smith Holston to Rep. Joe Barton (R-Tex.). Manufacturers' complaints regarding the panel chair's failure to abide by appropriate procedure at the Dental Panel's Oct. 13, 1994 meeting on muscle monitoring devices prompted the investigation.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008957

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel